These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8010081)

  • 1. Synthesis of a new hydroxyethylene dipeptide isostere Phe psi [CH2CH (OH)]Phe as HIV-1 protease inhibitor.
    Chen HG; Sawyer TK; Wuts PG
    Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):33-5. PubMed ID: 8010081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective synthesis of Xaa psi[CH2CH(OH)]Yaa dipeptidomimetics and their inclusion in HIV-1 protease inhibitors.
    Chen HG; Tustin JM; Wuts PG; Sawyer TK; Smith CW
    Int J Pept Protein Res; 1995 Jan; 45(1):1-10. PubMed ID: 7775003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient, stereoselective synthesis of the hydroxyethylene dipeptide isostere core for the HIV protease inhibitor A-792611.
    Engstrom K; Henry R; Hollis LS; Kotecki B; Marsden I; Pu YM; Wagaw S; Wang W
    J Org Chem; 2006 Jul; 71(14):5369-72. PubMed ID: 16808529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a Gln-Phe hydroxy-ethylene dipeptide isostere.
    Haug BE; Rich DH
    Org Lett; 2004 Dec; 6(25):4783-6. PubMed ID: 15575685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
    Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains.
    Tamamura H; Koh Y; Ueda S; Sasaki Y; Yamasaki T; Aoki M; Maeda K; Watai Y; Arikuni H; Otaka A; Mitsuya H; Fujii N
    J Med Chem; 2003 Apr; 46(9):1764-8. PubMed ID: 12699395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.
    Akaji K; Teruya K; Aimoto S
    J Org Chem; 2003 Jun; 68(12):4755-63. PubMed ID: 12790579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Tic-D-Phe Psi[CH2-CH2] isostere and its use in the development of melanocortin receptor agonists.
    Tian X; Chen X; Gan L; Hayes JC; Switzer AG; Solinsky MG; Ebetino FH; Wos JA; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1721-5. PubMed ID: 16376076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimetics.
    Ghosh AK; McKee SP; Sanders WM; Darke PL; Zugay JA; Emini EA; Schleif WA; Quintero JC; Huff JR; Anderson PS
    Drug Des Discov; 1993; 10(1):77-88. PubMed ID: 8399995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of potent HIV-1 protease inhibitors based on Phe-Pro dihydroxyethylene isosteres.
    Benedetti F; Berti F; Budal S; Campaner P; Dinon F; Tossi A; Argirova R; Genova P; Atanassov V; Hinkov A
    J Med Chem; 2012 Apr; 55(8):3900-10. PubMed ID: 22458611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
    Mimoto T; Kato R; Takaku H; Nojima S; Terashima K; Misawa S; Fukazawa T; Ueno T; Sato H; Shintani M; Kiso Y; Hayashi H
    J Med Chem; 1999 May; 42(10):1789-802. PubMed ID: 10346931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel HIV-protease inhibitors containing beta-hydroxyether and -thioether dipeptide isostere surrogates: modification of the P3 ligand.
    Patel NM; Bennett F; Girijavallabhan VM; Dasmahapatra B; Butkiewicz N; Hart A
    Bioorg Med Chem Lett; 1998 Apr; 8(8):931-4. PubMed ID: 9871514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of HIV-1 protease inhibitors. II. Incorporation of four types of hydroxyethylene dipeptide isosteres at the scissile site of substrate sequences.
    Sakurai M; Higashida S; Sugano M; Nishi T; Saito F; Ohata Y; Handa H; Komai T; Yagi R; Nishigaki T
    Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1378-86. PubMed ID: 8403086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug application.
    Kesteleyn B; Amssoms K; Schepens W; Hache G; Verschueren W; Van De Vreken W; Rombauts K; Meurs G; Sterkens P; Stoops B; Baert L; Austin N; Wegner J; Masungi C; Dierynck I; Lundgren S; Jönsson D; Parkes K; Kalayanov G; Wallberg H; Rosenquist A; Samuelsson B; Van Emelen K; Thuring JW
    Bioorg Med Chem Lett; 2013 Jan; 23(1):310-7. PubMed ID: 23177258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development.
    Bold G; Fässler A; Capraro HG; Cozens R; Klimkait T; Lazdins J; Mestan J; Poncioni B; Rösel J; Stover D; Tintelnot-Blomley M; Acemoglu F; Beck W; Boss E; Eschbach M; Hürlimann T; Masso E; Roussel S; Ucci-Stoll K; Wyss D; Lang M
    J Med Chem; 1998 Aug; 41(18):3387-401. PubMed ID: 9719591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.
    Young SD; Payne LS; Thompson WJ; Gaffin N; Lyle TA; Britcher SF; Graham SL; Schultz TH; Deana AA; Darke PL
    J Med Chem; 1992 May; 35(10):1702-9. PubMed ID: 1588552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of pseudopeptide inhibitors of HIV-1 aspartic protease: analysis and tuning of the subsite specificity.
    Tossi A; Antcheva N; Romeo D; Miertus S
    Pept Res; 1995; 8(6):328-34. PubMed ID: 8838416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-ketoamide Phe-Pro isostere as a new core structure for the inhibition of HIV protease.
    Munoz B; Giam CZ; Wong CH
    Bioorg Med Chem; 1994 Oct; 2(10):1085-90. PubMed ID: 7773625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
    Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
    J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.